EP1789089A4 - Compositions and treatments using ex vivo activated cells for myelosuppressed patients - Google Patents

Compositions and treatments using ex vivo activated cells for myelosuppressed patients

Info

Publication number
EP1789089A4
EP1789089A4 EP05802443A EP05802443A EP1789089A4 EP 1789089 A4 EP1789089 A4 EP 1789089A4 EP 05802443 A EP05802443 A EP 05802443A EP 05802443 A EP05802443 A EP 05802443A EP 1789089 A4 EP1789089 A4 EP 1789089A4
Authority
EP
European Patent Office
Prior art keywords
treatments
compositions
activated cells
vivo activated
myelosuppressed patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05802443A
Other languages
German (de)
French (fr)
Other versions
EP1789089A2 (en
Inventor
Demao Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/939,302 external-priority patent/US20060057121A1/en
Priority claimed from US10/939,168 external-priority patent/US7332158B2/en
Application filed by Individual filed Critical Individual
Publication of EP1789089A2 publication Critical patent/EP1789089A2/en
Publication of EP1789089A4 publication Critical patent/EP1789089A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
EP05802443A 2004-09-10 2005-08-05 Compositions and treatments using ex vivo activated cells for myelosuppressed patients Withdrawn EP1789089A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/939,302 US20060057121A1 (en) 2004-09-10 2004-09-10 Compositions and treatments using ex vivo activated cells for myelosuppressed patients
US10/939,168 US7332158B2 (en) 2002-05-29 2004-09-10 Compositions and treatments for myelosuppression by ex vivo activated immune cells
PCT/US2005/027949 WO2006031312A2 (en) 2004-09-10 2005-08-05 Compositions and treatments using ex vivo activated cells for myelosuppressed patients

Publications (2)

Publication Number Publication Date
EP1789089A2 EP1789089A2 (en) 2007-05-30
EP1789089A4 true EP1789089A4 (en) 2009-08-26

Family

ID=36060473

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05802443A Withdrawn EP1789089A4 (en) 2004-09-10 2005-08-05 Compositions and treatments using ex vivo activated cells for myelosuppressed patients

Country Status (3)

Country Link
EP (1) EP1789089A4 (en)
JP (1) JP2008512454A (en)
WO (1) WO2006031312A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190298766A1 (en) * 2018-03-29 2019-10-03 Demao Yang Cell therapy for patients

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056397A1 (en) * 2002-05-29 2004-07-08 Demao Yang Stimulation of hematopoiesis by ex vivo actived immune cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643786A (en) * 1995-01-27 1997-07-01 The United States Of America As Represented By The Department Of Health And Human Services Method for isolating dendritic cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056397A1 (en) * 2002-05-29 2004-07-08 Demao Yang Stimulation of hematopoiesis by ex vivo actived immune cells

Also Published As

Publication number Publication date
JP2008512454A (en) 2008-04-24
WO2006031312A3 (en) 2007-05-10
EP1789089A2 (en) 2007-05-30
WO2006031312A2 (en) 2006-03-23

Similar Documents

Publication Publication Date Title
EP1812102A4 (en) Occlusal stent and methods for its use
EP1895946A4 (en) Improvements relating in and to surgical implants
PL3111974T3 (en) Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
EP1731113A4 (en) Medical treatment kit
EP2061548A4 (en) Apparatus and methods for delivering stem cells and other agents into cardiac tissue
EP2180873A4 (en) Therapeutic dental composition and related methods
EP1758605A4 (en) Prouroguanylin as therapeutic and diagnostic agents
GB0426841D0 (en) Medical implant
EP1874800A4 (en) Diagnostic and therapeutic agents
EP1879449A4 (en) Compositions and methods for skin care
EP2083755A4 (en) Medical kit and using method thereof
EP1736173A4 (en) Damaged tissue therapeutic agent and therapeutic method
EP1781685A4 (en) Therapeutic and diagnostic agents
EP1998787A4 (en) Oral tissue regeneration and repair
EP1933853A4 (en) Tissue disruption treatment and composition for use thereof
PL2012805T3 (en) Therapeutic composition and use
PL1867352T3 (en) Anatomically implantable heart prosthesis in one piece
EP1781826A4 (en) Compositions and methods for diagnosis and treatment of orthopoxviruses
GB0406835D0 (en) Improvements in and relating to implants
EP1789089A4 (en) Compositions and treatments using ex vivo activated cells for myelosuppressed patients
GB2420976B (en) Therapeutic implant
EP1951914A4 (en) Diagnostic and therapeutic methods and agents
EP1812032A4 (en) Tissue factor composition and methods
GB0616725D0 (en) Improvements in and relating to implantable prostheses
GB0407718D0 (en) Improvements in and relating to surgical implants

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070327

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

R17D Deferred search report published (corrected)

Effective date: 20070510

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/06 20060101ALI20070606BHEP

Ipc: C07K 14/55 20060101ALI20070606BHEP

Ipc: C07K 14/52 20060101ALI20070606BHEP

Ipc: C07K 14/475 20060101ALI20070606BHEP

Ipc: A61K 35/14 20060101AFI20070606BHEP

DAX Request for extension of the european patent (deleted)
RBV Designated contracting states (corrected)

Designated state(s): DE ES FR GB

A4 Supplementary search report drawn up and despatched

Effective date: 20090728

17Q First examination report despatched

Effective date: 20091027

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130301